Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Tang Capital Partners Lp
Relationship:   10% Owner
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   15    
Direct Shares   123,746    

Indirect Shares

  35,438,120      
Direct Value   $27,818    

Indirect Value

  $75,698,131      
Total Shares   35,561,866      
Total Value   $75,725,949      


Ardea Biosciences Inc
 $0 Heron Therapeutics Inc
 $24,988 Northstar Neuroscience Inc
 $0 Molecular Templates, Inc.
 $2,831 Aradigm Corp
 $0 Ardea Biosciences Inc
 $0 Heron Therapeutics Inc
 $24,988 Northstar Neuroscience Inc
 $0 Molecular Templates, Inc.
 $2,831 Aradigm Corp
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    14   
    1    

     Stock price went up :

    3   
    0    
     Stock price went down :
    11   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -4.3%
 -74.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Ardea Biosciences Inc RDEA 10% Owner 2012-02-01 15,089 2012-02-01 3,800,634    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 2018-09-12 6,941 2018-09-12 5,844,562    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 2008-02-15 0 2008-02-19 25,953    Premium*  
            Northstar Neuroscience Inc NSTR 10% Owner 2008-11-18 27,000 2008-11-18 3,706,926    Premium*  
            Neose Technologies Inc NTEC 10% Owner 0 2008-09-30 10,412,306    Premium*  
            Molecular Templates, Inc. MTEM 10% Owner 2008-08-29 4,716 2008-09-29 785,920    Premium*  
            Vanda Pharmaceuticals Inc. VNDA 10% Owner 0 2010-01-14 2,715,852    Premium*  
            Aradigm Corp ARDM 10% Owner 2008-10-21 70,000 2008-10-21 5,877,000    Premium*  
            Penwest Pharmaceuticals Co PPCO 10% Owner 2009-01-09 0 2010-09-20 0    Premium*  
            La Jolla Pharmaceutical Co LJPC 0 2014-07-23 1,699,067    Premium*  
            Cyclacel Pharmaceuticals Inc CYCC 10% Owner 0 2017-02-23 559,900    Premium*  
            Aptevo Therapeutics Inc. APVO Exit Filing 2020-11-04 0 2021-11-23 0    Premium*  
            Jounce Therapeutics Inc JNCE 10% Owner 2023-03-13 0 2023-05-03 10,000    Premium*  
            Tcr2 Therapeutics Inc. TCRR 10% Owner 2023-05-03 0 2023-06-01 0    Premium*  
            Rain Therapeutics Inc. RAIN 10% Owner 2023-05-30 0 2024-01-26 0    Premium*  
* Premium Members only  

Records found :    176         Free Registration Required For Full Results.    Limit: 25

Download
  Page 6 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
NSTR Northstar Neuroscience In... 10% Owner   –       –       •   2008-05-14 4 B $1.80 $67,039 I/I 37,300 4,757,038 1.5 -
VNDA Vanda Pharmaceuticals Inc... 10% Owner   –       –       •   2008-09-19 4 B $0.98 $1,058,478 I/I 1,080,852 4,839,058 1.5 -
PPCO Penwest Pharmaceuticals C... 10% Owner   –       –       •   2009-01-09 4 B $1.99 $2,023,403 I/I 1,015,000 4,841,196 1.5 -
HRTX Heron Therapeutics Inc 10% Owner   –       –       •   2015-06-10 4 B $24.75 $2,999,997 I/I 121,212 4,867,530 1.5 -
VNDA Vanda Pharmaceuticals Inc... 10% Owner   –       –       •   2008-09-22 4 B $1.00 $99,880 I/I 100,000 4,939,058 1.5 -
VNDA Vanda Pharmaceuticals Inc... 10% Owner   –       –       •   2008-09-23 4 B $0.98 $78,520 I/I 80,000 5,019,058 1.5 -
JNCE Jounce Therapeutics Inc 10% Owner   –       –       •   2023-03-13 3 IO $0.00 $0 I/I 0 5,214,100 %
JNCE Jounce Therapeutics Inc 10% Owner   –       –       •   2023-03-13 4 B $0.99 $65,307 I/I 65,701 5,279,801 1.5 %
JNCE Jounce Therapeutics Inc 10% Owner   –       –       •   2023-03-14 4 B $1.02 $20,651 I/I 20,286 5,300,087 1.5 %
ARDM Aradigm Corp 10% Owner   –       –       •   2008-10-10 4 B $0.24 $10,602 I/I 45,000 5,355,000 1.5 -
HRTX Heron Therapeutics Inc 10% Owner   –       –       •   2008-09-30 4 B $0.97 $627,900 I/I 650,000 5,355,693 1.5 -
ARDM Aradigm Corp 10% Owner   –       –       •   2008-10-13 4 B $0.24 $6,000 I/I 25,000 5,380,000 1.5 -
ARDM Aradigm Corp 10% Owner   –       –       •   2008-10-20 4 B $0.24 $4,080 I/I 17,000 5,397,000 1.42 -
ARDM Aradigm Corp 10% Owner   –       –       •   2008-10-21 4 B $0.24 $2,400 I/I 10,000 5,407,000 1.42 -
PPCO Penwest Pharmaceuticals C... 10% Owner   –       –       •   2009-02-17 4 B $1.65 $1,096,652 I/I 665,000 5,506,196 1.5 -
PPCO Penwest Pharmaceuticals C... 10% Owner   –       –       •   2009-02-19 4 B $1.47 $66,258 I/I 45,000 5,551,196 1.5 -
PPCO Penwest Pharmaceuticals C... 10% Owner   –       –       •   2009-02-23 4 B $1.42 $34,238 I/I 24,140 5,575,336 1.5 -
PPCO Penwest Pharmaceuticals C... 10% Owner   –       –       •   2009-02-24 4 B $1.51 $1,967 I/I 1,300 5,576,636 1.42 -
VNDA Vanda Pharmaceuticals Inc... 10% Owner   –       –       •   2008-09-25 4 B $1.04 $622,680 I/I 600,000 5,619,058 1.5 -
PPCO Penwest Pharmaceuticals C... 10% Owner   –       –       •   2009-02-25 4 B $1.50 $103,572 I/I 69,200 5,645,836 1.5 -
PPCO Penwest Pharmaceuticals C... 10% Owner   –       –       •   2009-03-05 4 B $1.49 $126,761 I/I 85,000 5,730,836 1.5 -
HRTX Heron Therapeutics Inc 10% Owner   –       –       •   2018-09-12 4 S $35.75 $96,346,250 I/I (2,695,000) 5,830,215 0 -
HRTX Heron Therapeutics Inc 10% Owner   –       –       •   2016-06-16 4 D $18.47 $4,500,012 I/I (243,639) 5,873,891 0 -
PPCO Penwest Pharmaceuticals C... 10% Owner   –       –       •   2009-03-06 4 B $1.39 $437,307 I/I 309,300 6,040,136 1.5 -
HRTX Heron Therapeutics Inc 10% Owner   –       –       •   2016-06-16 4 OE $3.60 $4,500,000 I/I 1,250,000 6,117,530 0 -

  176  Records found
  1   2   3   4   5   6  7   8      
  Page 6 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed